Text messages to boost lung cancer screening participation
Official title: Advancing Lung Cancer Screening One Text at a Time
Run by University of Rochester · NCT07227480 · Data updated 2026-11-12
This trial will test whether sending tailored text messages to adults aged 50–80 with a 20+ pack-year smoking history can increase completion of lung cancer screening compared with mailed educational materials.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years to 80 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | University of Rochester Academic / other |
| Locations | 1 site (Rochester, New York) |
| Status | Recruiting |
| Started | February 17, 2026 |
| Main results expected | August 2026 |
| Study ends | August 2026 |
| Registry record updated | February 19, 2026 |
| Trial ID | NCT07227480 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 50–80 with a 20+ pack-year smoking history who currently smoke or quit within the past 15 years, are not up-to-date on annual screening, speak English or Spanish, have a working cellphone with unlimited texting, and are willing to complete baseline and 3-month surveys.
✕Probably not a fit
Patients already up-to-date on annual lung cancer screening, those without a text-capable phone or unlimited texting, those outside the age/pack-year criteria, or non-English/Spanish speakers may not benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a two-arm pilot randomized controlled trial enrolling 40 adults who are not up-to-date on annual lung cancer screening. Participants will be randomized 1:1 to receive UR Screened, a text-messaging program designed to promote lung cancer screening, or to a control arm that receives mailed educational material and a flyer about the screening program. The study will measure recruitment and follow-up rates, participant satisfaction with the intervention or materials, and uptake of lung cancer screening at week 12. Screening rates will be compared between the intervention and control groups to estimate preliminary impact.
Why it matters
Potential benefit: If successful, the text-messaging approach could increase screening uptake and lead to earlier detection of lung cancer in eligible patients.
How similar studies have gone: Text-message interventions have improved uptake in some other cancer screening programs but have been less tested specifically for lung cancer screening, making this pilot relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 50 to 80 years old * have not completed their annual screening for lung cancer * have a 20 pack-year smoking history * currently smoke or have quit within the past 15 years * speak English and/or Spanish * have a functioning cellphone number with unlimited text messaging capacity * be willing to complete a baseline and a follow-up (at Month 3) survey Exclusion Criteria: * being up-to-date on their annual lung cancer screening
Where it's running
-
University of Rochester Medical Center
Rochester, New York, United States Recruiting
Study contacts
- Study coordinator: Francisco Cartujano, MD
- Email: francisco_cartujano@urmc.rochester.edu
- Phone: (585) 273-1646
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Empowering patients to get lung cancer screening with support and navigation
This pilot study tests a patient navigation and education program to see if it helps adults who are eligible start and complete low-dose CT lung cancer screening.
-
Quality Implementation of Lung Cancer Screening in Kentucky
This project tests how well the QUILS system helps Kentucky lung cancer screening programs work together to screen at-risk residents more effectively.
-
Statewide Lung Cancer Screening Improvement in Nevada and Mississippi using the QUILS System
This project tests whether a QUILS-based statewide initiative can expand and sustain high-quality lung cancer screening for people in Mississippi and Nevada.
-
Quality Improvement Implementation for Lung Cancer Screening (QUILS) Program Enhancement
This project tests a quality improvement pathway in existing lung cancer screening programs to help identify and prioritize process changes that improve quality and patient retention.
-
Methylation markers from saliva to guide lung cancer screening
This study tests whether DNA methylation patterns in saliva can more accurately identify people who should get a low-dose CT scan for lung cancer screening.
-
Multilevel program to increase LDCT lung cancer screening and help African American smokers quit
This program will try combining low-dose CT screening with culturally tailored smoking-cessation support to help African American smokers who are eligible for LDCT quit and get screened.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.